Navigation Links
Elsevier launches new journal: International Journal of Paleopathology
Date:5/31/2011

Oxford, May 31, 2011 Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, International Journal of Paleopathology, the official journal of the Paleopathology Association. Published quarterly, the first issue of the journal is now freely available to view online on SciVerse ScienceDirect. Print copies of the first issue will be available at the 7th World Congress on Mummy Studies on 12-16 June 2011 in San Diego, USA, where Elsevier will host a reception to officially launch the journal.

Editor-in-Chief Professor Jane E. Buikstra of Arizona State University said, "I am energized by the challenge of creating an academic journal format that seeks to encourage research and foster interdisciplinary communication. As the only dedicated paleopathology journal in the community, we are extremely proud to have the designation of "Official Journal of the Paleopathology Association".

The International Journal of Paleopathology will publish original and significant articles on human and animal (including hominids) disease. The articles are based on the study of physical remains, including osseous, dental, and preserved soft tissues at a range of methodological levels, from direct observation to molecular, chemical, histological and radiographic analysis. Discussion of ways in which these methods can be applied to the reconstruction of health, disease and life histories in the past is central to the discipline. This way the journal would also encourage papers covering interpretive and theoretical issues, and those that place the study of disease at the centre of a bioarchaeological or biocultural approach.

Papers dealing with historical evidence relating to disease in the past - rather than with history of medicine - will also be published. The journal will also accept significant studies that apply previously developed techni
'/>"/>

Contact: Lyndsay Scholefield
l.scholefield@elsevier.com
44-186-584-3825
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Elseviers new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content
2. Elseviers Journal of Evidence-Based Dental Practice celebrates 10th year with special issue
3. Elsevier launches Carpentiers reconstructive valve surgery book
4. Elsevier introduces Cardiac Electrophysiology Clinics
5. Elsevier and InfoDesk collaborate to co-develop federated drug pipeline intelligence solution
6. Elsevier acquires Collexis
7. Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology
8. Elsevier partners with ASRT to provide multimedia educational modules through Mosbys Imaging Suite
9. Elsevier partners with Helinet to strengthen consortiums leadership in health sciences education
10. Gold Standard/Elsevier promotes medication safety and compliance via New MEDcounselor languages
11. Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Bronx, NY (PRWEB) , ... September 01, 2015 , ... ... for 86 children and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place ... camp staff included 65 adult counselors, some of whom work for Calvary, and two ...
(Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly prefer to have ... Surgery, according to a new survey that also offers insight on why that ... – which reflects views on cosmetic medical treatments and ratings for 10 specific ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and resolves ... treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its ... disciplines since its inception more than 35 years ago. A pilot program begun by ... teachers - and, not just those intent on pursuing careers in these fields. The ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Nelson, D.O., has joined its medical management team as an Associate Medical Director. ... all sizes and types in the U.S. and abroad. , Dr. Nelson ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3
... (LTR) at the LSU Health Sciences Center New Orleans ... million contract over seven years by the National Cancer ... Epidemiology and End Results) Program-designated cancer registry. There are ... States., "The SEER Program is the most authoritative source ...
... if therapeutic anticancer vaccines, which are designed to boost ... developed. For example, the viruses used to deliver the ... targeted by the patient,s immune system, inducing neutralizing and ... by Michael Morse, at Duke University Medical Center, Durham, ...
... By Amanda Gardner HealthDay Reporter , MONDAY, Aug. ... to fashion a therapeutic vaccine that appears to attack a ... required tumor-fighting immune response in early human trials, but only ... urged caution. "They were able to generate an immune ...
... N.C., Aug. 2 - Merz Pharmaceuticals today announced that ... has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type ... or blepharospasm. According to an epidemiology study conducted in ... cervical dystonia and blepharospasm, is estimated at 295 per ...
... able to significantly reduce the radiation dose associated with ... one day dose optimization workshop provided by the Royal ... supported by the local state health department, according to ... Journal of the American College of Radiology (www.jacr.org). ...
... A study in the Aug. 1 issue of the journal ... age male infants are easier to arouse than females during quiet ... no significant gender differences in arousability. The results suggest that ... may not reflect a pre-existing vulnerability involving arousal responses. Results ...
Cached Medicine News:Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 2Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 3Health News:Vaccine Shows Some Promise Against Advanced Cancers 2Health News:FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm 2Health News:FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm 3Health News:FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm 4Health News:SIDS surprise: Study finds that infant boys are more easily aroused from sleep than girls 2Health News:SIDS surprise: Study finds that infant boys are more easily aroused from sleep than girls 3
(Date:9/1/2015)... SPRINGDALE, Ark. , Sept. 1, 2015 NOWDiagnostics Inc., ... completed its acquisition of ZBx Corporation of Canada ... to its vision of a world where people have ... NOWDiagnostics manufactures and sells a line of unique blood-based ... simple-to-use, highly accurate tests for a variety of ailments ...
(Date:9/1/2015)... 1, 2015 UT Southwestern Medical Center President ... members joined U.S. Representatives Michael C. Burgess , ... discussion on the 21 st Century Cures Act, ... considered by the United States ... Academy of Sciences members, department chairs, center directors, and ...
(Date:9/1/2015)... Sept. 1, 2015  Results from an interim analysis ... that 5g of idarucizumab enabled emergency surgery to ... treated with dabigatran (Pradaxa ® dabigatran etexilate ... effect of dabigatran enabled patients to be urgently ... of 1.7 hours between administration of idarucizumab and ...
Breaking Medicine Technology:NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 4U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9
... in wake of AHA-presented data , ... a clinical trial suggesting rosuvastatin may lower the cardiovascular risk ... statin use in older adults, according to a national poll ... the online poll conducted by medical news site MedPage Today ...
... FRANCISCO, Calif., Nov. 25 Poniard,Pharmaceuticals, Inc. (Nasdaq: ... on,innovative oncology therapies, announced today that it will ... in order to allow,the Company to focus its ... product candidate, and to support the initial commercialization ...
Cached Medicine Technology:Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3
... Right Solution For Your Tracheostomy Care Needs, ... tray features the latest components for efficient ... control task. Designed by clinicians, these latex-free ... each patient and caregiver. All of our ...
... Right Solution For Your Tracheostomy Care Needs, ... tray features the latest components for efficient ... control task. Designed by clinicians, these latex-free ... each patient and caregiver. All of our ...
... alternate care facilities with a wide ... offer the finest in nursing convenience ... guidance of experienced nursing personnel, these ... is required for efficient and quick ...
... alternate care facilities with a wide ... offer the finest in nursing convenience ... guidance of experienced nursing personnel, these ... is required for efficient and quick ...
Medicine Products: